Correlation Between Molecular Partners and Absci Corp
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Absci Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Absci Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Absci Corp, you can compare the effects of market volatilities on Molecular Partners and Absci Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Absci Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Absci Corp.
Diversification Opportunities for Molecular Partners and Absci Corp
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Molecular and Absci is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Absci Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Absci Corp and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Absci Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Absci Corp has no effect on the direction of Molecular Partners i.e., Molecular Partners and Absci Corp go up and down completely randomly.
Pair Corralation between Molecular Partners and Absci Corp
Given the investment horizon of 90 days Molecular Partners AG is expected to under-perform the Absci Corp. In addition to that, Molecular Partners is 1.06 times more volatile than Absci Corp. It trades about -0.26 of its total potential returns per unit of risk. Absci Corp is currently generating about -0.02 per unit of volatility. If you would invest 449.00 in Absci Corp on June 24, 2024 and sell it today you would lose (17.00) from holding Absci Corp or give up 3.79% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Molecular Partners AG vs. Absci Corp
Performance |
Timeline |
Molecular Partners |
Absci Corp |
Molecular Partners and Absci Corp Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Molecular Partners and Absci Corp
The main advantage of trading using opposite Molecular Partners and Absci Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Absci Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Absci Corp will offset losses from the drop in Absci Corp's long position.Molecular Partners vs. HCW Biologics | Molecular Partners vs. RenovoRx | Molecular Partners vs. Scpharmaceuticals | Molecular Partners vs. Milestone Pharmaceuticals |
Absci Corp vs. Recursion Pharmaceuticals | Absci Corp vs. Affimed NV | Absci Corp vs. Sana Biotechnology | Absci Corp vs. Relay Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |